• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在组织干细胞/祖细胞区室以及人类癌症中,整体5-羟甲基胞嘧啶含量显著降低。

Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.

作者信息

Haffner Michael C, Chaux Alcides, Meeker Alan K, Esopi David M, Gerber Jonathan, Pellakuru Laxmi G, Toubaji Antoun, Argani Pedram, Iacobuzio-Donahue Christine, Nelson William G, Netto George J, De Marzo Angelo M, Yegnasubramanian Srinivasan

机构信息

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.

出版信息

Oncotarget. 2011 Aug;2(8):627-37. doi: 10.18632/oncotarget.316.

DOI:10.18632/oncotarget.316
PMID:21896958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3248214/
Abstract

DNA methylation at the 5-position of cytosines (5 mC) represents an important epigenetic modification involved in tissue differentiation and is frequently altered in cancer. Recent evidence suggests that 5 mC can be converted to 5-hydroxymethylcytosine (5 hmC) in an enzymatic process involving members of the TET protein family. Such 5 hmC modifications are known to be prevalent in DNA of embryonic stem cells and in the brain, but the distribution of 5 hmC in the majority of embryonic and adult tissues has not been rigorously explored. Here, we describe an immunohistochemical detection method for 5 hmC and the application of this technique to study the distribution of 5 hmC in a large set of mouse and human tissues. We found that 5 hmC was abundant in the majority of embryonic and adult tissues. Additionally, the level of 5 hmC closely tracked with the differentiation state of cells in hierarchically organized tissues. The highest 5 hmC levels were observed in terminally differentiated cells, while less differentiated tissue stem/progenitor cell compartments had very low 5 hmC levels. Furthermore, 5 hmC levels were profoundly reduced in carcinoma of the prostate, breast and colon compared to normal tissues. Our findings suggest a distinct role for 5 hmC in tissue differentiation, and provide evidence for its large-scale loss in cancers.

摘要

胞嘧啶5位的DNA甲基化(5 mC)是一种重要的表观遗传修饰,参与组织分化,且在癌症中经常发生改变。最近的证据表明,在涉及TET蛋白家族成员的酶促过程中,5 mC可转化为5-羟甲基胞嘧啶(5 hmC)。已知这种5 hmC修饰在胚胎干细胞和大脑的DNA中普遍存在,但尚未对大多数胚胎组织和成年组织中5 hmC的分布进行严格探究。在此,我们描述了一种用于检测5 hmC的免疫组织化学方法,并将该技术应用于研究大量小鼠和人类组织中5 hmC的分布。我们发现,5 hmC在大多数胚胎组织和成年组织中含量丰富。此外,在分层组织的组织中,5 hmC的水平与细胞的分化状态密切相关。在终末分化细胞中观察到最高的5 hmC水平,而分化程度较低的组织干/祖细胞区室的5 hmC水平非常低。此外,与正常组织相比,前列腺癌、乳腺癌和结肠癌中的5 hmC水平显著降低。我们的研究结果表明5 hmC在组织分化中具有独特作用,并为其在癌症中大规模缺失提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/9a1673e24552/oncotarget-02-627-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/885bea51f9bd/oncotarget-02-627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/fc4344f773f5/oncotarget-02-627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/6ee494a4e7c9/oncotarget-02-627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/7109ecd8fa2a/oncotarget-02-627-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/9a1673e24552/oncotarget-02-627-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/885bea51f9bd/oncotarget-02-627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/fc4344f773f5/oncotarget-02-627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/6ee494a4e7c9/oncotarget-02-627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/7109ecd8fa2a/oncotarget-02-627-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743b/3248214/9a1673e24552/oncotarget-02-627-g005.jpg

相似文献

1
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.在组织干细胞/祖细胞区室以及人类癌症中,整体5-羟甲基胞嘧啶含量显著降低。
Oncotarget. 2011 Aug;2(8):627-37. doi: 10.18632/oncotarget.316.
2
High sensitivity 5-hydroxymethylcytosine detection in Balb/C brain tissue.Balb/C脑组织中高灵敏度5-羟甲基胞嘧啶的检测
J Vis Exp. 2011 Feb 1(48):2661. doi: 10.3791/2661.
3
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.TET催化的5-羟甲基胞嘧啶调控分化中的结肠细胞和结肠癌中的基因表达。
Sci Rep. 2015 Dec 3;5:17568. doi: 10.1038/srep17568.
4
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development.在哺乳动物发育过程中,基因组 5-羟甲基胞嘧啶的特异性谱系分布。
Cell Res. 2011 Sep;21(9):1332-42. doi: 10.1038/cr.2011.113. Epub 2011 Jul 12.
5
Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry.采用毛细管亲水作用色谱/四极杆飞行时间质谱法对肝癌组织基因组 DNA 中的 5-甲基胞嘧啶和 5-羟甲基胞嘧啶进行定量分析。
Clin Chem. 2013 May;59(5):824-32. doi: 10.1373/clinchem.2012.193938. Epub 2013 Jan 23.
6
Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.全球5-羟甲基胞嘧啶水平降低是乳腺癌患者预后不良的一个因素,尤其是对于雌激素受体/孕激素受体阴性亚型患者而言。
Breast Cancer Res Treat. 2015 Aug;153(1):219-34. doi: 10.1007/s10549-015-3525-x. Epub 2015 Aug 8.
7
Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.5-羟甲基胞嘧啶的减少与 TET1 的下调有关,通过下调 TET1 促进肝癌的进展。
PLoS One. 2013 May 9;8(5):e62828. doi: 10.1371/journal.pone.0062828. Print 2013.
8
TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.食管癌中的TET家族蛋白与5-羟甲基胞嘧啶
Oncotarget. 2015 Sep 15;6(27):23372-82. doi: 10.18632/oncotarget.4281.
9
Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.5-羟甲基胞嘧啶(5-hmC)降低是胃癌患者的一个独立不良预后因素。
J Biomed Nanotechnol. 2013 Sep;9(9):1607-16. doi: 10.1166/jbn.2013.1713.
10
Array-based assay detects genome-wide 5-mC and 5-hmC in the brains of humans, non-human primates, and mice.基于芯片的检测方法可检测人类、非人灵长类动物和小鼠大脑中的全基因组5-甲基胞嘧啶(5-mC)和5-羟甲基胞嘧啶(5-hmC)。
BMC Genomics. 2014 Feb 13;15:131. doi: 10.1186/1471-2164-15-131.

引用本文的文献

1
Ten-Eleven Translocation Family Proteins: Structure, Biological Functions, Diseases, and Targeted Therapy.10-11易位家族蛋白:结构、生物学功能、疾病及靶向治疗
MedComm (2020). 2025 Jul 1;6(7):e70245. doi: 10.1002/mco2.70245. eCollection 2025 Jul.
2
5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells.5-羟甲基胞嘧啶增强PARP捕获并恢复化疗耐药的BRCA1/2缺陷细胞对PARP抑制剂的敏感性。
J Biol Chem. 2025 Jul;301(7):110393. doi: 10.1016/j.jbc.2025.110393. Epub 2025 Jun 19.
3
DNA Methylation and Demethylation in Triple-Negative Breast Cancer: Associations with Clinicopathological Characteristics and the Chemotherapy Response.

本文引用的文献

1
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.TET2 基因的十十一易位 2 负向调控了小鼠造血干细胞的自我更新和分化。
Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14566-71. doi: 10.1073/pnas.1112317108. Epub 2011 Aug 22.
2
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development.在哺乳动物发育过程中,基因组 5-羟甲基胞嘧啶的特异性谱系分布。
Cell Res. 2011 Sep;21(9):1332-42. doi: 10.1038/cr.2011.113. Epub 2011 Jul 12.
3
Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain.
三阴性乳腺癌中的DNA甲基化与去甲基化:与临床病理特征及化疗反应的关联
Biomedicines. 2025 Feb 26;13(3):585. doi: 10.3390/biomedicines13030585.
4
TET-mediated 5hmC in breast cancer: mechanism and clinical potential.TET介导的5-羟甲基胞嘧啶在乳腺癌中的作用:机制与临床潜力
Epigenetics. 2025 Dec;20(1):2473250. doi: 10.1080/15592294.2025.2473250. Epub 2025 Feb 27.
5
Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications.游离细胞 DNA 羟甲基化在癌症中的应用:当前和新兴的检测方法及临床应用。
Genes (Basel). 2024 Sep 3;15(9):1160. doi: 10.3390/genes15091160.
6
An Overview of Global, Local, and Base-Resolution Methods for the Detection of 5-Hydroxymethylcytosine in Genomic DNA.全球、局部和基于碱基分辨率方法检测基因组 DNA 中的 5-羟甲基胞嘧啶概述。
Methods Mol Biol. 2024;2842:325-352. doi: 10.1007/978-1-0716-4051-7_17.
7
Ultrasensitive detection of 5-hydroxymethylcytosine in genomic DNA using a graphene-based sensor modified with biotin and gold nanoparticles.使用生物素和金纳米粒子修饰的基于石墨烯的传感器对基因组DNA中的5-羟甲基胞嘧啶进行超灵敏检测。
Mater Today Bio. 2024 Jun 11;27:101123. doi: 10.1016/j.mtbio.2024.101123. eCollection 2024 Aug.
8
Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.在子宫颈癌前病变进展过程中抑制胞嘧啶 5-羟甲基化。
PLoS One. 2024 Apr 18;19(4):e0297008. doi: 10.1371/journal.pone.0297008. eCollection 2024.
9
Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line.研究 sFRP1 蛋白对慢性髓系白血病细胞系中参与 DNA 甲基化调控的分子的影响。
Med Oncol. 2024 Apr 9;41(5):109. doi: 10.1007/s12032-024-02336-2.
10
The level of active DNA demethylation compounds in leukocytes and urine samples as potential epigenetic biomarkers in breast cancer patients.白细胞和尿液样本中活性 DNA 去甲基化化合物作为乳腺癌患者潜在的表观遗传生物标志物的水平。
Sci Rep. 2024 Mar 18;14(1):6481. doi: 10.1038/s41598-024-56326-5.
Uhrf1 SRA 结构域对 5-羟甲基胞嘧啶的识别。
PLoS One. 2011;6(6):e21306. doi: 10.1371/journal.pone.0021306. Epub 2011 Jun 22.
4
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.Tet2 缺失导致造血干细胞自我更新和髓系转化增加。
Cancer Cell. 2011 Jul 12;20(1):11-24. doi: 10.1016/j.ccr.2011.06.001. Epub 2011 Jun 30.
5
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair.胸腺嘧啶 DNA 糖基化酶是通过链接的脱氨碱基切除修复进行主动 DNA 去甲基化所必需的。
Cell. 2011 Jul 8;146(1):67-79. doi: 10.1016/j.cell.2011.06.020. Epub 2011 Jun 30.
6
The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression.5-羟甲基胞嘧啶在基因启动子而非基因体中的存在会负调控基因表达。
Biochem Biophys Res Commun. 2011 Jul 22;411(1):40-3. doi: 10.1016/j.bbrc.2011.06.077. Epub 2011 Jun 15.
7
Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines.鉴定常见前列腺癌细胞系中的复制型鼠γ逆转录病毒。
PLoS One. 2011;6(6):e20874. doi: 10.1371/journal.pone.0020874. Epub 2011 Jun 17.
8
5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells.5-羟甲基胞嘧啶与人类胚胎干细胞中的增强子和基因体有关。
Genome Biol. 2011 Jun 20;12(6):R54. doi: 10.1186/gb-2011-12-6-r54.
9
Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia.基因组5-羟甲基胞嘧啶水平与继发性急性髓系白血病中的TET2突变及独特的整体基因表达模式相关。
Leukemia. 2011 Oct;25(10):1649-52. doi: 10.1038/leu.2011.134. Epub 2011 May 31.
10
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells.胚胎干细胞中 5-羟甲基胞嘧啶的全基因组图谱绘制。
Nature. 2011 May 19;473(7347):394-7. doi: 10.1038/nature10102. Epub 2011 May 8.